馬用サプリメント製品の世界市場：産業規模、シェア、動向、機会、予測 - サプリメント別、用途別、流通チャネル別、地域別、競合別、2019～2029年

世界の馬用サプリメント製品の市場規模は、2023年に8,445万米ドルに達し、2029年までの予測期間中にCAGR 4.12%の着実な成長が予測されています。

世界の馬用サプリメント製品市場は、馬の多様なヘルスケアニーズに対応することで大きな成長と進化を遂げています。馬産業の拡大と馬の健康に対する意識の高まりが牽引するこの市場は、馬に特化した幅広い治療介入を包含しています。市場の成長を支えているのは、高度な獣医学的治療、予防医療、馬術競技の急増に対する需要の高まりです。ここでいう治療薬には、馬のさまざまな健康状態を管理するための投薬、ワクチン、リハビリテーションサービスなどが含まれます。重要な促進要因のひとつは、馬のパフォーマンス向上と予防ヘルスケアが馬の分野で重視されていることです。馬の健康や長生きを優先する馬主や愛好家の増加に伴い、病気だけでなく全体的な健康やパフォーマンスをサポートする獣医学的治療薬への需要が高まっています。

馬のスポーツイベントや競合の世界化が市場の拡大に寄与しています。レース、障害飛越、馬場馬術など、さまざまな競技に参加する馬は、そのパフォーマンスを最適化し、福祉を確保するために専門的な獣医学的ケアを必要とします。このため、馬特有の生理学やヘルスケアニーズに合わせた革新的な治療ソリューションが開発されています。この市場の特徴は、抗感染薬、抗炎症薬、ワクチン、サプリメントなど、多様な製品とサービスです。また、診断および治療方法における技術的進歩は、馬の獣医学的治療法の展望を形成する上で重要な役割を果たしています。同市場における調査課題としては、馬の国際移動に伴う規制の複雑さ、不要不急のヘルスケアへの支出に影響する経済的制約、専門的な研究資金の必要性などが挙げられます。しかし、産業利害関係者間の協力努力、バイオテクノロジーの進歩、馬ヘルスケアにおける倫理的配慮の重視が、これらの課題の克服に寄与しています。馬産業が成長と世界化を続ける中、世界の馬用サプリメント製品市場は、世界の多様な馬の人口のダイナミックなヘルスケア要件に対応し、持続的な拡大が期待できる位置にあります。

主な市場促進要因

馬産業の成長

予防ヘルスケアの重視

馬術スポーツイベントの増加

主な市場課題

規制遵守

限られた研究資金

主要市場動向

生物製剤の採用増加

馬用治療薬市場の世界化

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の馬用サプリメント製品の市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サプリメント別
  • 用途別
  • 流通チャネル別
  • 地域別
  • 企業別（2023年）
• 市場マップ
  • サプリメント別
  • 用途別
  • 流通チャネル別
  • 地域別

第6章 アジア太平洋の馬用サプリメント製品の市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サプリメント別
  • 用途別
  • 流通チャネル別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州の馬用サプリメント製品の市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サプリメント別
  • 用途別
  • 流通チャネル別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米の馬用サプリメント製品の市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サプリメント別
  • 用途別
  • 流通チャネル別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米の馬用サプリメント製品の市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サプリメント別
  • 用途別
  • 流通チャネル別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの馬用サプリメント製品の市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サプリメント別
  • 用途別
  • 流通チャネル別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の馬用サプリメント製品市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 産業内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Bayer AG
• Boehringer Ingelheim International GmbH
• Equine Products UK Ltd
• Zoetis Services LLC
• Purina Animal Nutrition LLC
• Vetoquinol S.A.
• Kentucky Equine Research, Inc.
• Plusvital Limited
• Lallemand Inc.
• Virbac S.A.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Equine Supplement Products Market was valued at USD 84.45 Million in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 4.12% through 2029. The Global Equine Supplement Products Market is experiencing significant growth and evolution as it addresses the diverse healthcare needs of horses. This market, driven by the expanding equine industry and the increasing awareness of equine health, encompasses a broad spectrum of therapeutic interventions tailored specifically for horses. The market's growth is underpinned by a rising demand for advanced veterinary treatments, preventive care, and a surge in equine sporting events. Therapeutics in this context include medications, vaccines, and rehabilitation services designed to manage various health conditions in horses. One key driver is the heightened emphasis on performance enhancement and preventive healthcare in the equine sector. With a growing number of horse owners and enthusiasts prioritizing the well-being and longevity of their animals, there is an increased demand for veterinary therapeutics that address not only diseases but also support overall health and performance.

The globalization of equine sporting events and competitions contributes to the expansion of the market. Horses participating in various disciplines, such as racing, show jumping, and dressage, require specialized veterinary care to optimize their performance and ensure their welfare. This has led to the development of innovative therapeutic solutions tailored to the unique physiology and healthcare needs of horses. The market is characterized by a diverse range of products and services, including anti-infectives, anti-inflammatory drugs, vaccines, and supplements. Also, technological advancements in diagnostics and treatment modalities play a crucial role in shaping the equine veterinary therapeutics landscape. Challenges in the market include regulatory complexities associated with international movement of horses, economic constraints affecting spending on non-essential healthcare, and the need for specialized research funding. However, collaborative efforts between industry stakeholders, advancements in biotechnology, and a focus on ethical considerations in equine healthcare contribute to overcoming these challenges. As the equine industry continues to grow and globalize, the Global Equine Supplement Products Market is positioned for sustained expansion, addressing the dynamic healthcare requirements of the diverse equine population worldwide.

Key Market Drivers

Growing Equine Industry

The Global Equine Supplement Products Market is significantly influenced by the burgeoning growth of the equine industry worldwide. The rising popularity of equestrian sports, recreational riding, and other equine-related activities has resulted in an increased population of horses globally. As the equine industry expands, so does the demand for effective and specialized veterinary therapeutics to address the health and well-being of these animals. Horse owners and professionals within the equine sector are increasingly recognizing the importance of investing in veterinary care to maintain the health, performance, and longevity of their equine companions. The growing equine industry encompasses a spectrum of activities, including horse racing, show jumping, dressage, and leisure riding. Each of these disciplines requires unique veterinary interventions, ranging from preventive healthcare measures to therapeutic treatments for specific conditions. With a heightened awareness of the economic and emotional value associated with horses, owners are more inclined to seek advanced veterinary solutions to optimize the health and performance of their equine partners. This escalating demand for equine veterinary therapeutics is driving innovation within the market, prompting pharmaceutical companies and research institutions to develop specialized medications, diagnostics, and treatment protocols. As the equine industry continues to flourish, the Global Equine Supplement Products Market is positioned for sustained growth, fueled by the evolving healthcare needs of the diverse equine population around the world.

Emphasis on Preventive Healthcare

The Global Equine Supplement Products Market is experiencing a notable surge driven by a growing emphasis on preventive healthcare within the equine industry. Horse owners and professionals are increasingly recognizing the value of proactive measures to maintain the health and well-being of their equine companions. This shift towards preventive healthcare in the equine sector includes a focus on vaccinations, deworming, nutritional supplements, and routine veterinary check-ups. The aim is to prevent diseases, detect potential health issues early, and optimize the overall health of horses. The emphasis on preventive healthcare is propelled by a desire to enhance the longevity and performance of horses, particularly those involved in various equestrian disciplines. As the understanding of equine physiology advances, there is a growing awareness of the importance of nutrition, vaccinations, and regular health monitoring in preventing common ailments. This trend aligns with the broader movement towards responsible horse ownership and the recognition of horses as valuable and cherished companions. In response to this emphasis on prevention, the equine veterinary therapeutics market is witnessing an increased demand for vaccines, anthelmintics, and nutritional supplements tailored to the unique needs of horses. Pharmaceutical companies are developing innovative and effective preventive solutions to address the evolving healthcare preferences within the equine industry. As the awareness of preventive healthcare practices continues to grow, the Global Equine Supplement Products Market is poised for sustained expansion, meeting the rising demand for therapeutics that contribute to the overall well-being of horses.

Rise in Equine Sporting Events

The Global Equine Supplement Products Market is experiencing a significant upswing propelled by the burgeoning rise in equine sporting events globally. The expansion of horse racing, show jumping, dressage, and other equestrian competitions has created a heightened demand for specialized veterinary care and therapeutics. Horses participating in these events undergo rigorous training and face unique health challenges, necessitating advanced healthcare interventions to enhance their performance and ensure their overall well-being. As the equine sporting industry continues to grow, the market for veterinary therapeutics is witnessing a surge in demand for medications, performance-enhancing supplements, and rehabilitation services tailored to the specific needs of these high-performance animals. The nature of equine sports places exceptional demands on the health and fitness of participating horses, leading to an increased focus on injury prevention, recovery, and optimal performance. Veterinary therapeutics, ranging from anti-inflammatory drugs to regenerative medicine, play a crucial role in addressing the unique healthcare requirements of sport horses. This trend aligns with the broader recognition of horses as valuable athletes, prompting owners, trainers, and event organizers to prioritize top-tier veterinary care to ensure the welfare of the competing animals. As the popularity and economic significance of equine sporting events continue to grow, the Global Equine Supplement Products Market is poised for sustained expansion. This trend not only reflects the evolving healthcare needs of performance horses but also underscores the market's responsiveness to the dynamic landscape of the global equine industry.

Key Market Challenges

Regulatory Compliance

Regulatory compliance is a critical aspect that significantly influences the dynamics of the Global Equine Supplement Products Market. The complex and varied regulatory landscape governing veterinary pharmaceuticals poses challenges for companies operating in this market. As equine veterinary therapeutics are subject to different regulations in various regions, navigating this intricate web of compliance requirements becomes essential for market participants. The regulatory environment encompasses product registration, marketing authorization, and adherence to specific standards and guidelines set forth by regulatory bodies. In the United States, the Food and Drug Administration (FDA) oversees the approval and regulation of veterinary drugs, ensuring their safety, efficacy, and proper labeling. The European Medicines Agency (EMA) plays a similar role in the European Union, establishing regulations for veterinary medicines. However, within the EU, each member state also maintains its own regulatory framework, adding another layer of complexity for companies seeking market approval. The diverse regulatory landscape extends beyond North America and Europe, with countries in Asia-Pacific, Latin America, and other regions having their own sets of rules and requirements. Harmonization efforts, such as the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH), aim to align regulatory standards globally.

Despite these efforts, challenges persist due to variations in regulatory interpretations and local nuances. Meeting regulatory compliance demands rigorous documentation of the safety and efficacy of equine veterinary therapeutics. This involves extensive preclinical and clinical studies, data submission, and adherence to good manufacturing practices (GMP). Ensuring product safety is particularly crucial, given the unique physiology of horses and the potential impact of therapeutic interventions on their well-being. The regulatory approval process often involves rigorous scrutiny of study designs, data integrity, and the ethical treatment of animals involved in trials. Ethical considerations related to equine health and welfare are paramount, and regulatory bodies emphasize the humane treatment of animals throughout the development and testing phases. The timeframe and cost associated with obtaining regulatory approvals can be substantial. Delays in approval processes can impede the timely entry of new equine veterinary therapeutics into the market, affecting companies' revenue projections and hindering their ability to address emerging health challenges in the equine population promptly. Moreover, the complexity of regulatory requirements poses a particular challenge for small and medium-sized enterprises (SMEs) in the equine veterinary therapeutics market. SMEs may lack the resources and expertise to navigate the intricate regulatory pathways, potentially limiting their ability to bring innovative products to market.

Limited Research Funding

Limited research funding poses a significant challenge to the Global Equine Supplement Products Market, impeding the progress of innovative solutions and hindering the industry's ability to address emerging health issues in the equine population. In the realm of veterinary medicine, where research and development are crucial for advancing therapeutic interventions, the availability of funding plays a pivotal role in shaping the trajectory of scientific breakthroughs. The equine veterinary therapeutics market is characterized by its unique set of challenges and opportunities, necessitating targeted research to develop effective medications, vaccines, and treatment modalities tailored to the distinct physiology of horses. However, compared to more mainstream fields, such as human medicine or even companion animal therapeutics, funding dedicated to equine health research is often limited, creating a gap in knowledge and innovation. One of the primary factors contributing to the limited research funding in equine veterinary therapeutics is the comparatively smaller market size. With horses constituting a niche segment of the overall veterinary market, attracting investment and research funding can be challenging. Pharmaceutical companies and research institutions may prioritize areas with larger market potential, leaving equine health research with constrained financial support. The lack of a robust commercial market for certain equine health issues further exacerbates the funding challenge. Conditions specific to horses, such as certain infectious diseases or less common ailments, may not attract sufficient attention from funding bodies due to their limited economic impact or the perception that they affect only a small population of animals.

Moreover, the cost-intensive nature of equine research poses a hurdle. Conducting clinical trials, maintaining research facilities, and ensuring the ethical treatment of research animals, all integral components of equine health studies, require substantial financial resources. The high cost associated with equine veterinary research may discourage potential funders, limiting the scope and scale of research initiatives. Another contributing factor to the funding constraint is the lack of centralized funding bodies dedicated exclusively to equine health. Unlike some other areas of veterinary research, such as companion animal health or food animal production, equine health may not benefit from dedicated funding agencies or foundations that prioritize and allocate resources specifically for equine research. The limited collaboration between academia and industry in the equine veterinary therapeutics sector also contributes to constrained research funding. Collaborations between universities, research institutions, and pharmaceutical companies can facilitate the translation of research findings into practical applications. However, the scarcity of such collaborative initiatives in the equine sector hampers the flow of funds into critical research endeavors.

To address the challenge of limited research funding, concerted efforts are required from various stakeholders. Pharmaceutical companies operating in the equine veterinary therapeutics market can play a pivotal role by allocating resources to support research initiatives, recognizing the long-term benefits of a robust evidence base for their products. Collaborations between industry and academia can foster a synergistic approach, leveraging the strengths of both sectors to advance equine health research. Government agencies and private foundations dedicated to animal health research can contribute by prioritizing equine health within their funding initiatives. Establishing targeted grant programs and fostering a supportive environment for equine research can encourage scientists and veterinarians to explore innovative solutions for equine health challenges. Also, advocacy for equine health research within the broader veterinary and animal welfare community is crucial. Raising awareness about the importance of equine health, both in terms of the animals' welfare and the economic contributions of the equine industry, can garner support from diverse funding sources. Educational institutions can also play a role in addressing the funding gap by incorporating equine health into their research priorities. By encouraging faculty and students to pursue research projects in equine veterinary therapeutics, universities contribute to expanding the knowledge base and addressing the specific healthcare needs of horses.

Key Market Trends

Increasing Adoption of Biologics

The Global Equine Supplement Products Market is experiencing a noteworthy trend with the increasing adoption of biologics. Biologic products, which include monoclonal antibodies, cytokine therapies, and other advanced biological agents, have gained prominence as innovative treatment modalities for various equine health conditions. These biologics offer targeted and specific interventions, often addressing complex diseases and disorders with a higher degree of precision. The trend reflects a shift towards personalized and advanced therapeutic approaches in equine healthcare. One notable area of adoption is in the field of regenerative medicine, where biologics like stem cell therapy and platelet-rich plasma (PRP) have demonstrated efficacy in promoting tissue repair and accelerating the healing process in horses. These regenerative therapies hold promise for addressing musculoskeletal injuries, a common concern in equine sports and activities. The use of monoclonal antibodies and cytokine therapies is also gaining traction, particularly in the management of inflammatory conditions and immune-related disorders in horses. These biologics, designed to modulate specific pathways in the immune system, offer novel and targeted solutions for conditions that may have been challenging to address with traditional pharmaceuticals. The increasing adoption of biologics in the equine veterinary therapeutics market signifies a growing understanding of the unique physiology of horses and the potential benefits of tailored, biologically derived treatments. As research and development in this domain continue to advance, biologics are likely to play an increasingly pivotal role in shaping the future of equine healthcare, offering new possibilities for improving the overall well-being and performance of horses.

Globalization of Equine Therapeutics Market

The Global Equine Supplement Products Market is undergoing a transformative phase marked by the globalization of its landscape. The equine industry's increasing internationalization and the global movement of horses have significantly influenced the dynamics of the therapeutics market. This trend is propelled by the growing participation of horses in various global events, such as equestrian sports competitions, breeding programs, and international trade. As horses traverse borders for racing, breeding, and leisure, there is a heightened demand for standardized and internationally recognized equine veterinary therapeutics. The globalization of the equine therapeutics market has implications for regulatory harmonization and the development of consistent treatment protocols. Regulatory frameworks are evolving to accommodate the cross-border movement of horses, necessitating alignment and collaboration between regulatory bodies worldwide. This shift facilitates a more seamless introduction of equine veterinary therapeutics in different regions, ensuring that products meet standardized safety and efficacy requirements. Moreover, the sharing of knowledge, research findings, and best practices on a global scale is fostering collaboration between veterinarians, researchers, and pharmaceutical companies. This exchange of information contributes to the development of innovative solutions that cater to the diverse healthcare needs of horses across different geographical locations. The globalization trend not only expands market opportunities for equine veterinary therapeutics but also underscores the need for a comprehensive and interconnected approach to equine healthcare on a global scale. As the equine industry continues to transcend borders, the Global Equine Supplement Products Market is poised to benefit from increased collaboration, regulatory alignment, and the development of universally applicable therapeutic solutions for horses worldwide.

Segmental Insights

Supplements Insights

Based on Supplements, Protein have emerged as the fastest growing segment in the Global Equine Supplement Products Market in 2023. This is ascribed due to its crucial role in supporting the overall health and performance of horses. Proteins are essential for muscle development, tissue repair, and overall body maintenance in equines. Equine enthusiasts, trainers, and veterinarians prioritize protein-rich supplements to enhance muscle strength, promote recovery, and support the horse's energy levels. As protein plays a fundamental role in equine nutrition, supplements catering to this specific need are in high demand, driving the dominance of the protein segment in the market for equine supplement products worldwide.

Distribution Channel Insights

Based on Distribution Channel, Veterinary Hospital have emerged as the dominating segment in the Global Equine Supplement Products Market in 2023. This is because of its role as a trusted source for comprehensive equine healthcare. Veterinary hospitals, with their specialized expertise, recommend and administer supplements tailored to individual horse needs. They provide a professional environment for assessing nutritional requirements and addressing specific health concerns, ensuring accurate supplement recommendations. Moreover, veterinary hospitals maintain quality standards, influencing the preference for supplements prescribed within a clinical setting. Horse owners often rely on the expertise of veterinary professionals in these institutions, contributing to the dominance of the veterinary hospitals segment in the global market for equine supplement products.

Regional Insights

Based on Region, North America have emerged as the dominating region in the Global Equine Supplement Products Market in 2023. The region is home to a large population of horses, with a thriving equestrian industry comprising various disciplines such as racing, showing, and recreational riding. This substantial equine population drives demand for supplements to maintain horse health and performance. North America boasts a well-established network of equine veterinarians and professionals who recommend and prescribe supplements as part of routine care. The region's robust economy and high disposable income levels among horse owners facilitate increased spending on premium supplement products. These factors position North America as a key player in the Global Equine Supplement Products Market.

Key Market Players

Bayer AG

Boehringer Ingelheim International GmbH

Equine Products UK Ltd

Zoetis Services LLC

Purina Animal Nutrition LLC

Vetoquinol S.A.

Kentucky Equine Research, Inc.

Plusvital Limited

Lallemand Inc.

Virbac S.A.

Report Scope:

In this report, the Global Equine Supplement Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Supplement Products Market, By Supplements:

Protein Vitamin Enzyme Electrolyte & Minerals Others

Equine Supplement Products Market, By Application:

Performance Enhancement/Recovery Joint Disorder Prevention Other

Equine Supplement Products Market, By Distribution Channel:

Veterinary Hospital Veterinary Clinics Pharmacies and drug stores E-commerce Other

Equine Supplement Products Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Equine Supplement Products Market.

Available Customizations:

Global Equine Supplement Products Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Supplement Products Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Supplements (Protein, Vitamin, Enzyme, Electrolyte & Minerals, Others)
  • 5.2.2. By Application (Performance Enhancement/Recovery, Joint Disorder Prevention, Other)
  • 5.2.3. By Distribution Channel (Veterinary Hospital, Veterinary Clinics, Pharmacies and drug stores, E-commerce, Other)
  • 5.2.4. By Region
  • 5.2.5. By Company (2023)
• 5.3. Market Map
  • 5.3.1. By Supplements
  • 5.3.2. By Application
  • 5.3.3. By Distribution Channel
  • 5.3.4. By Region

6. Asia Pacific Equine Supplement Products Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Supplements
  • 6.2.2. By Application
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Equine Supplement Products Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Supplements
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. India Equine Supplement Products Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Supplements
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Australia Equine Supplement Products Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Supplements
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Distribution Channel
  • 6.3.4. Japan Equine Supplement Products Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Supplements
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By Distribution Channel
  • 6.3.5. South Korea Equine Supplement Products Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Supplements
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By Distribution Channel

7. Europe Equine Supplement Products Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Supplements
  • 7.2.2. By Application
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Equine Supplement Products Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Supplements
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. Germany Equine Supplement Products Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Supplements
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. Spain Equine Supplement Products Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Supplements
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Equine Supplement Products Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Supplements
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. United Kingdom Equine Supplement Products Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Supplements
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Distribution Channel

8. North America Equine Supplement Products Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Supplements
  • 8.2.2. By Application
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Equine Supplement Products Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Supplements
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. Mexico Equine Supplement Products Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Supplements
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Canada Equine Supplement Products Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Supplements
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Distribution Channel

9. South America Equine Supplement Products Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Supplements
  • 9.2.2. By Application
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Equine Supplement Products Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Supplements
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Equine Supplement Products Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Supplements
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Equine Supplement Products Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Supplements
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Equine Supplement Products Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Supplements
  • 10.2.2. By Application
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Equine Supplement Products Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Supplements
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Equine Supplement Products Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Supplements
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Equine Supplement Products Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Supplements
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Distribution Channel
  • 10.3.4. Egypt Equine Supplement Products Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Supplements
      • 10.3.4.2.2. By Application
      • 10.3.4.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Equine Supplement Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Bayer AG
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (In case of listed)
  • 15.1.5. Recent Developments
  • 15.1.6. SWOT Analysis
• 15.2. Boehringer Ingelheim International GmbH
• 15.3. Equine Products UK Ltd
• 15.4. Zoetis Services LLC
• 15.5. Purina Animal Nutrition LLC
• 15.6. Vetoquinol S.A.
• 15.7. Kentucky Equine Research, Inc.
• 15.8. Plusvital Limited
• 15.9. Lallemand Inc.
• 15.10. Virbac S.A.

16. Strategic Recommendations

17. About Us & Disclaimer